2805. Extended-Infusion versus Intermittent-Infusion Piperacillin/tazobactam for High Minimum Inhibitory Concentration Pseudomonas aeruginosa Infections

BACKGROUND: Extended-infusion (EI) piperacillin/tazobactam, compared to intermittent-infusion (II) piperacillin/tazobactam, has been associated with improved clinical outcomes for both critically ill and febrile neutropenic patients. However, there is a paucity of data on whether these clinical bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Shifko, Carlee R, Carr, Dustin R, Walsh, Thomas L, Moffa, Matthew A, Shively, Nathan R, Bremmer, Derek N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678606/
http://dx.doi.org/10.1093/ofid/ofad500.2416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678606/
http://dx.doi.org/10.1093/ofid/ofad500.2416

Ejemplares similares